[Skip to Navigation]
Sign In
Comment & Response
January 2019

Competing Risks for a Diagnosis of Invasive Breast Cancer

Author Affiliations
  • 1Yong Loo Lin School of Medicine, National University of Singapore, Singapore
JAMA Oncol. 2019;5(1):110-111. doi:10.1001/jamaoncol.2018.5058

To the Editor In their recent article in JAMA Oncology, Brentnall et al1 reported on long-term results from a praiseworthy cohort study that observed women who completed a breast cancer risk assessment until the diagnosis of invasive breast cancer or censoring. Women were censored at death, diagnosis of ductal carcinoma in situ, when they reached 75 years of age, or at the end of study follow-up.

Add or change institution